Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Xilio Therapeutics (XLO) EBIAT (2024 - 2025)

Historic EBIAT for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to -$1.9 million.

  • Xilio Therapeutics' EBIAT rose 8624.11% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.7 million, marking a year-over-year change of. This contributed to the annual value of -$58.2 million for FY2024, which is N/A changed from last year.
  • Xilio Therapeutics' EBIAT amounted to -$1.9 million in Q3 2025, which was up 8624.11% from -$14.4 million recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' EBIAT registered a high of -$1.9 million during Q3 2025, and its lowest value of -$14.4 million during Q2 2025.